| Net Cash Provided by (Used in) Operating Activities |
$1,999,680 |
USD |
62% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,870,254 |
USD |
-45% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$4,578 |
USD |
87% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
1,560,153 |
shares |
1027% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$930,693 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,220,654 |
USD |
708% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$20,111,374 |
USD |
-1.6% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$20,121,659 |
USD |
-1.7% |
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$4,578 |
USD |
152% |
Q1 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$11,198,172 |
USD |
82% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$24,412 |
USD |
-80% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$121,567 |
USD |
|
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$15,628,885 |
USD |
17% |
Q4 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$56,000 |
USD |
|
Q3 2024 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$17,713 |
USD |
-33% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$147,835,989 |
USD |
16% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
| Amortization of Intangible Assets |
$198,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Depreciation, Depletion and Amortization |
$206,700 |
USD |
12073% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$10,285 |
USD |
-59% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$74,267 |
USD |
-83% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |